Literature DB >> 19411560

Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells.

Cc Huang1, Cj Huang, Js Cheng, Si Liu, Is Chen, Jy Tsai, Ct Chou, Pl Tseng, Cr Jan.   

Abstract

The effect of fendiline on cytosolic free Ca(2+) concentrations ([Ca(2+)](i)) and proliferation has not been explored in human oral cancer cells. This study examined whether fendiline altered Ca(2+) levels and caused cell death in OC2 human oral cancer cells. [Ca(2+)](i) and cell viability were measured using the fluorescent dyes fura-2 and WST-1, respectively. Fendiline at concentrations above 10 microM increased [Ca(2+)](i) in a concentration-dependent manner. The Ca(2+) signal was reduced partly by removing extracellular Ca(2+). The fendiline-induced Ca(2+) influx was sensitive to blockade of L-type Ca(2+) channel blockers. In Ca(2+)-free medium, after pretreatment with 50 microM fendiline, 1 microM thapsigargin (an endoplasmic reticulum Ca(2+) pump inhibitor)-induced [Ca(2+)](i) rises were inhibited; and conversely, thapsigargin pretreatment nearly abolished fendiline-induced [Ca(2+)](i) rises. Inhibition of phospholipase C with 2 microM U73122 did not change fendiline-induced [Ca(2+)](i) rises. At concentrations between 5 and 25 microM, fendiline killed cells in a concentration-dependent manner. The cytotoxic effect of 15 microM fendiline was not reversed by prechelating cytosolic Ca(2+) with BAPTA/AM. Collectively, in OC2 cells, fendiline induced [Ca(2+)](i) rises by causing Ca(2+) release from the endoplasmic reticulum and Ca(2+) influx from L-type Ca(2+) channels. Furthermore, fendiline-caused cytotoxicity was not via a preceding [Ca(2+)](i) rise.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411560     DOI: 10.1177/0960327108097436

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.

Authors:  Wenwen Chien; Qiao-Yang Sun; Kian Leong Lee; Ling-Wen Ding; Peer Wuensche; Lucia A Torres-Fernandez; Siew Zhuan Tan; Itay Tokatly; Norazean Zaiden; Lorenz Poellinger; Seiichi Mori; Henry Yang; Jeffrey W Tyner; H Phillip Koeffler
Journal:  Mol Oncol       Date:  2015-01-15       Impact factor: 6.603

2.  Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.

Authors:  Dharini van der Hoeven; Kwang-jin Cho; Xiaoping Ma; Sravanthi Chigurupati; Robert G Parton; John F Hancock
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

3.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 4.  Vomocytosis: Too Much Booze, Base, or Calcium?

Authors:  Melissa Cruz-Acuña; Noah Pacifici; Jamal S Lewis
Journal:  mBio       Date:  2019-12-24       Impact factor: 7.867

5.  Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment.

Authors:  Antonella Brizzolara; Patrizia Garbati; Serena Vella; Matilde Calderoni; Alessandro Quattrone; Gian Paolo Tonini; Mario Capasso; Luca Longo; Raffaella Barbieri; Tullio Florio; Aldo Pagano
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

6.  Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice.

Authors:  Patrizia Garbati; Raffaella Barbieri; Matilde Calderoni; Francesca Baldini; Mario Nizzari; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

7.  Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages.

Authors:  Sweta Samantaray; Joao N Correia; Mariam Garelnabi; Kerstin Voelz; Robin C May; Rebecca A Hall
Journal:  Int J Antimicrob Agents       Date:  2016-05-26       Impact factor: 5.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.